Mach-1 Financial Group »

Intra Cellular Therapies shares owned by Mach-1 Financial Group

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Mach-1 Financial Group from 13F filings

Historical chart of Mach-1 Financial Group investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Mach-1 Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Mach-1 Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $514k 7.2k 71.62
2022-12-31 $584k 11k 52.93

More positions owned by Mach-1 Financial Group

First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
First Tr Exchng Traded Fd Vi Cboe Vest Us Eq (BUFR)
Wal-Mart Stores (WMT)
Spdr Index Shs Fds Msci Acwi Exus (CWI)
Microsoft Corporation (MSFT)
First Tr Value Line Divid In SHS (FVD)
First Tr Exchange-traded Ft Cboe Vest S&p (KNG)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
First Tr Morningstar Divid L SHS (FDL)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
JPMorgan Chase & Co. (JPM)
Wells Fargo & Company (WFC)
First Tr Exchange-traded Smid Risng Etf (SDVY)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)

View all positions for Mach-1 Financial Group

Top funds holding Intra Cellular Therapies

Vanguard Group
Daniel D. Thurber
Bellevue Group
venBio Select Advisor
Jpmorgan Chase & Co
Alliancebernstein
Franklin Resources
Wellington Management Company
Jennifer Ranahan
ClearBridge Advisors
Holocene Advisors
T. Rowe Price Associates
Norges Bank Investment Management
Charles Schwab Investment Management
Lord, Abbett & Co

View all funds holding Intra Cellular Therapies